| Original language | English |
|---|---|
| Pages (from-to) | 1-10 |
| Number of pages | 10 |
| Journal | Clinical Infectious Diseases |
| Volume | 20 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1995 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Escherichia coli 0157:H7 : Clinical, diagnostic, and epidemiological aspects of human infection. / Tarr, Phillip I.
In: Clinical Infectious Diseases, Vol. 20, No. 1, 01.1995, p. 1-10.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Escherichia coli 0157:H7
T2 - Clinical, diagnostic, and epidemiological aspects of human infection
AU - Tarr, Phillip I.
N1 - Funding Information: This test affords you the opportunity to assess your knowledge and understanding of the material presented in the preceding clinical article, "Escherichia coli 0157:H7: Clinical, Diagnostic, and Epidemiological Aspects of Human Infection," by Phillip I. Tarr, and to earn continuing medical education (CME) credit. The Office of Continuing Medical Education, UCLA School of Medicine, is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The Office of Continuing Medical Education, UCLA School of Medicine, certifies that this continuing medical education activity meets the criteria for I credit hour in Category I of the Physician's Recognition Award of the American Medical Association and the California Medical Association Certificate in Continuing Medical Education. To earn credit, read the State-of-the-Art Clinical Article carefully and answer the following questions. Mark your answer by circling the correct responses on the answer card (usually found toward the front of the issue) and mail after affixing first class postage. To earn credit, a minimum score of 80% must be obtained. Certificates of CME credit will be awarded on a per volume (biannual) basis. Each answer card must be submitted within 3 months of the date of issue. This program is made possible by an educational grant from Roche Laboratories. Funding Information: Received 7 September 1994. Financial support: Dr. Tarr is the recipient of an AGA/Blackwell Scientific Publications Research Scholar Award and a Crohn's Colitis Foundation of America Research Grant. Reprints or correspondence: Dr. Phillip I. Tarr, Division ofGastroenterol-ogy, CH-24, Children's Hospital and Medical Center, 4800 Sand Point Way NE, Seattle, Washington 98105.
PY - 1995/1
Y1 - 1995/1
UR - http://www.scopus.com/inward/record.url?scp=0028801764&partnerID=8YFLogxK
U2 - 10.1093/clinids/20.1.1
DO - 10.1093/clinids/20.1.1
M3 - Article
C2 - 7727633
AN - SCOPUS:0028801764
VL - 20
SP - 1
EP - 10
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - 1
ER -